Literature DB >> 22706728

Usefulness of EQ-5D for evaluation of health-related quality of life in young adults with first-episode psychosis.

J Stochl1, T Croudace, J Perez, M Birchwood, H Lester, M Marshall, T Amos, V Sharma, D Fowler, P B Jones.   

Abstract

PURPOSE: To evaluate the psychometric properties of the EQ-5D and the usefulness of this instrument in psychiatric practice as a measure of health-related quality of life (HRQoL) in a sample of young adults with first-episode psychosis.
METHODS: The validity of individual questionnaire items is studied using an Item Response/Latent Trait Theory modeling approach. Sensitivity of response patterns on EQ-5D items to particular diagnostic subtypes of psychosis is investigated using a finite mixture modeling approach through latent class analysis. Finally, a structural equation modeling framework is used to study differential item functioning via a multigroup approach.
RESULTS: Results suggest that the data closely correspond to the Rasch Rating Scale Model, and therefore that EQ-5D latent scores are equal interval measures. Despite comprising relatively few items, the instrument yields reliable measures of HRQoL for group comparisons and cost-effectiveness evaluation, but EQ-5D score is too imprecise for the assessment of HRQoL for clinical purposes at the individual level. A significant relationship was found between EQ-5D responses and type of psychosis due to inclusion of item anxiety/depression in EQ-5D. Two items (anxiety/depression, functioning in usual activities) showed an ethnicity bias.
CONCLUSIONS: Psychometric evidence confirmed the EQ-5D to be a valid, interval measure that is scalable according to Rasch principles.

Entities:  

Mesh:

Year:  2012        PMID: 22706728     DOI: 10.1007/s11136-012-0222-7

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  27 in total

Review 1.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

2.  Measuring health-related quality of life in bipolar disorder: relationship of the EuroQol (EQ-5D) to condition-specific measures.

Authors:  Hazel Hayhurst; Stephen Palmer; Rosemary Abbott; Tony Johnson; Jan Scott
Journal:  Qual Life Res       Date:  2006-09-14       Impact factor: 4.147

3.  A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system.

Authors:  P McGuffin; A Farmer; I Harvey
Journal:  Arch Gen Psychiatry       Date:  1991-08

4.  The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties.

Authors: 
Journal:  Soc Sci Med       Date:  1998-06       Impact factor: 4.634

5.  Validity of the EQ-5D in assessing and valuing health status in patients with schizophrenic, schizotypal or delusional disorders.

Authors:  Hans-Helmut König; Christiane Roick; Matthias C Angermeyer
Journal:  Eur Psychiatry       Date:  2006-12-04       Impact factor: 5.361

6.  EuroQol EQ-5D and condition-specific measures of health outcome in women with urinary incontinence: reliability, validity and responsiveness.

Authors:  Kirstie L Haywood; Andrew M Garratt; Ranjit Lall; Jan Fereday Smith; Sarah E Lamb
Journal:  Qual Life Res       Date:  2008-02-15       Impact factor: 4.147

7.  Psychometric validation of a generic health-related quality of life measure (EQ-5D) in a sample of schizophrenic patients.

Authors:  L Prieto; J A Sacristán; J A Hormaechea; A Casado; X Badia; J C Gómez
Journal:  Curr Med Res Opin       Date:  2004-06       Impact factor: 2.580

8.  A comparison of the EQ-5D and SF-6D across seven patient groups.

Authors:  John Brazier; Jennifer Roberts; Aki Tsuchiya; Jan Busschbach
Journal:  Health Econ       Date:  2004-09       Impact factor: 3.046

9.  Is the EQ-5D fit for purpose in mental health?

Authors:  John Brazier
Journal:  Br J Psychiatry       Date:  2010-11       Impact factor: 9.319

10.  Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorder.

Authors:  Christophe Sapin; Bruno Fantino; Marie-Laure Nowicki; Paul Kind
Journal:  Health Qual Life Outcomes       Date:  2004-05-05       Impact factor: 3.186

View more
  5 in total

1.  Psychometric properties of the EuroQol Five Dimensional Questionnaire (EQ-5D-3L) in caregivers of autistic children.

Authors:  Rahul Khanna; Krutika Jariwala; John P Bentley
Journal:  Qual Life Res       Date:  2013-04-25       Impact factor: 4.147

2.  Development, validity and reliability of the short multidimensional positive mental health instrument.

Authors:  Janhavi Ajit Vaingankar; Mythily Subramaniam; Edimansyah Abdin; Louisa Picco; Boon Yiang Chua; Goi Khia Eng; Rajeswari Sambasivam; Saleha Shafie; Yunjue Zhang; Siow Ann Chong
Journal:  Qual Life Res       Date:  2013-12-04       Impact factor: 4.147

Review 3.  Assessing quality of life in psychosocial and mental health disorders in children: a comprehensive overview and appraisal of generic health related quality of life measures.

Authors:  Jochen O Mierau; Daphne Kann-Weedage; Pieter J Hoekstra; Lisan Spiegelaar; Danielle E M C Jansen; Karin M Vermeulen; Sijmen A Reijneveld; Barbara J van den Hoofdakker; Erik Buskens; M Elske van den Akker-van Marle; Carmen D Dirksen; Annabeth P Groenman
Journal:  BMC Pediatr       Date:  2020-07-03       Impact factor: 2.125

4.  Psychometric properties of Short Form-36 Health Survey, EuroQol 5-dimensions, and Hospital Anxiety and Depression Scale in patients with chronic pain.

Authors:  Riccardo LoMartire; Björn Olov Äng; Björn Gerdle; Linda Vixner
Journal:  Pain       Date:  2020-01       Impact factor: 7.926

5.  Treating common mental disorder including psychotic experiences in the primary care improving access to psychological therapies programme (the TYPPEX study): protocol for a stepped wedge cluster randomised controlled trial with nested economic and process evaluation of a training package for therapists.

Authors:  Polly-Anna Ashford; Clare Knight; Margaret Heslin; Allan B Clark; Mona Kanaan; Ushma Patel; Freya Stuart; Thomas Kabir; Nick Grey; Hannah Murray; J Hodgekins; Nesta Reeve; Nicola Marshall; Michelle Painter; James Clarke; Debra Russo; Jan Stochl; Maria Leathersich; Martin Pond; David Fowler; Paul French; Ann Marie Swart; Mary Dixon-Woods; Sarah Byford; Peter B Jones; Jesus Perez
Journal:  BMJ Open       Date:  2022-06-22       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.